Image not available
Image not available
Image not available

In 1999, STORZ MEDICAL was the first manufacturer worldwide to introduce a cardiological shock wave system for the treatment of refractory angina pectoris. During the last few years, the company has conducted ongoing research in close co-operation with leading medical institutes and continuously improved shock wave therapy for cardiological applications.

Today, many renowned therapy centres use the innovative MODULITH® SLC with great success in the treatment of Non-revascularizable Angina Pectoris, Ischemic Heart Disease (HF), No-reflow after PCI, Diffuse Coronary Artery Disease.

MODULITH SLC
Literature
Patient Information

STORZ MEDICAL AG
Lohstampfestrasse 8
8274 Tägerwilen
Switzerland
Tel.: +41 (0)71 677 45 45
Fax: +41 (0)71 677 45 05

www.storzmedical.com
Personal data
Address
Contact data
Message